These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1333687)

  • 1. Immunogenicity of inactivated purified tissue culture vaccine against hepatitis A (HepAvac) assessed in laboratory rodents.
    Elbert LB; Lisitzina EA; Kusov YY; Balayan MS
    Vaccine; 1992; 10(12):828-32. PubMed ID: 1333687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenicity of a cultured inactivated hepatitis A vaccine].
    Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV
    Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.
    Wiedermann G; Ambrosch F; Kollaritsch H; Hofmann H; Kunz C; D'Hondt E; Delem A; André FE; Safary A; Stéphenne J
    Vaccine; 1990 Dec; 8(6):581-4. PubMed ID: 1965077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and immunogenicity of an inactivated hepatitis A vaccine.
    Pellegrini V; Fineschi N; Matteucci G; Marsili I; Nencioni L; Puddu M; Garelick H; Zuckerman AJ
    Vaccine; 1993; 11(3):383-7. PubMed ID: 8383387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents.
    Poovorawan Y; Kosuwon P; Sutra S; Theamboonlers A; Vimolket T; Safary A
    Asian Pac J Allergy Immunol; 1998; 16(2-3):111-7. PubMed ID: 9876949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
    Binn LN; MacArthy PO; Marchwicki RH; Sjogren MH; Hoke CH; Burge JR; D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S102-5. PubMed ID: 1335636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.
    Flehmig B; Heinricy U; Pfisterer M
    Lancet; 1989 May; 1(8646):1039-41. PubMed ID: 2565998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults.
    McMahon BJ; Williams J; Bulkow L; Snowball M; Wainwright R; Kennedy M; Krause D
    J Infect Dis; 1995 Mar; 171(3):676-9. PubMed ID: 7876615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops.
    Hopperus Buma AP; van Doornum GJ; Veltink RL; van Ameijden EJ; Leentvaar-Kuijpers A; Coutinho RA
    Vaccine; 1997; 15(12-13):1413-7. PubMed ID: 9302753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up.
    Lee WT; Chang MH; Lee CY; Chen DS; Safary A; Andre FE
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):331-5. PubMed ID: 8607357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production, quality control and characterization of an inactivated hepatitis A vaccine.
    Peetermans J
    Vaccine; 1992; 10 Suppl 1():S99-101. PubMed ID: 1335671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais.
    Poovorawan Y; Theamboonlers A; Chumdermpadetsuk S; Glück R; Cryz SJ
    Vaccine; 1995 Jul; 13(10):891-3. PubMed ID: 7483760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.